{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:26:56Z","timestamp":1791901616748,"version":"4.3.4"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Women with maturity-onset diabetes of the young (MODY) need tailored antenatal care and monitoring of their offspring. Each MODY subtype has different implications for glycaemic targets, treatment choices and neonatal management. Hyperglycaemia of MODY is often first diagnosed in adolescence or early adulthood and therefore is clinically relevant to pregnant women. MODY remains an under-recognised and undiagnosed condition. Pregnancy represents an opportune time to make a genetic diagnosis of MODY and provide precision treatment. This review describes the nuance of antenatal care in women with MODY and the implications for pregnancies affected by a positive paternal genotype. Mutations in hepatic nuclear factor 1-alpha (<jats:italic>HNF1A<\/jats:italic>) and 4-alpha (<jats:italic>HNF4A<\/jats:italic>) genes are associated with progressive \u03b2-cell dysfunction resulting in early onset diabetes. Patients are largely managed with sulphonylureas outside of pregnancy. Macrosomia and persistent neonatal hypoglycaemia are reported in 54% and 15% of <jats:italic>HNF4A<\/jats:italic> genotype positive offspring respectively with a median increase in birthweight of 790\u00a0g. Close observation of foetal growth <jats:italic>in utero<\/jats:italic> allows optimal timing of delivery to minimise peri- and postpartum materno-foetal complications. Glucokinase (<jats:italic>GCK<\/jats:italic>)-MODY causes mild fasting hyperglycaemia which does not require treatment outside of pregnancy. Birthweight of offspring of maternal carriers is dependent on foetal genotype; heterozygous mutation carriers are usually normal weight while genotype negative offspring are large for gestational age (600\u00a0g heavier). Affected offspring of paternal carriers may be small for gestational age (500\u00a0g lighter). Serial growth scans with measurement of the abdominal circumference indirectly differentiate foetal genotype. Measurement of cell free foetal DNA in maternal blood from the late first trimester is superior to traditionally used ultrasound to distinguish foetal genotype. Cost and accessibility may limit its use.<\/jats:p>","DOI":"10.3389\/fgene.2024.1362977","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:26:21Z","timestamp":1718166381000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Management of pregnancy in women with monogenic diabetes due to mutations in GCK, HNF1A and HNF4A genes"],"prefix":"10.3389","volume":"15","author":[{"given":"M. T.","family":"Crowley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Paponette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"B2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00592-016-0890-9","article-title":"Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood","volume":"53","author":"Bacon","year":"","journal-title":"Acta Diabetol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/dme.12992","article-title":"Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort","volume":"33","author":"Bacon","year":"","journal-title":"Diabet. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"236.e1","DOI":"10.1016\/j.ajog.2015.04.037","article-title":"The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young","volume":"213","author":"Bacon","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"h102","DOI":"10.1136\/bmj.h102","article-title":"Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis","volume":"350","author":"Balsells","year":"2015","journal-title":"Bmj"},{"key":"B6","article-title":"A TCF1 mutation may cause transient congenital hyperinsulinism followed by MODY3","volume":"11","author":"Brusgaard","year":"2006","journal-title":"Endocr. Abstr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2337\/diab.44.6.699","article-title":"Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20","volume":"44","author":"Byrne","year":"1995","journal-title":"Diabetes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2337\/diab.45.11.1503","article-title":"Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12","volume":"45","author":"Byrne","year":"1996","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jamapediatrics.2015.74","article-title":"Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes","volume":"169","author":"Camelo Castillo","year":"2015","journal-title":"JAMA Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2337\/dc12-0151","article-title":"Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment","volume":"35","author":"Chakera","year":"2012","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc13-2248","article-title":"The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort","volume":"37","author":"Chakera","year":"2014","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2337\/dc14-2769","article-title":"Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation","volume":"38","author":"Chakera","year":"2015","journal-title":"Diabetes Care"},{"key":"B64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmet.2018.08.001","article-title":"Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes","volume":"17","author":"Chakera","year":"2018","journal-title":"Mol. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/dme.13180","article-title":"Analysis of cell-free fetal DNA for non-invasive prenatal diagnosis in a family with neonatal diabetes","volume":"34","author":"De Franco","year":"2017","journal-title":"Diabet. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00592-018-1267-z","article-title":"Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry","volume":"56","author":"Dickens","year":"2019","journal-title":"Acta Diabetol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/db23-183-lb","article-title":"183-LB: a randomized placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (emerge)","volume":"72","author":"Dunne","year":"2023","journal-title":"Diabetes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1515\/jpem.2011.083","article-title":"HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes","volume":"24","author":"Dusatkova","year":"2011","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S254","DOI":"10.2337\/dc23-S015","article-title":"15. Management of diabetes in pregnancy: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2022","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2337\/diacare.28.8.1851","article-title":"Transfer of glyburide and glipizide into breast milk","volume":"28","author":"Feig","year":"2005","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1530\/EJE-09-0861","article-title":"Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations","volume":"162","author":"Flanagan","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/356162a0","article-title":"Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus","volume":"356","author":"Froguel","year":"1992","journal-title":"Nature"},{"key":"B22","first-page":"377","article-title":"Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations","volume":"26","author":"Guenat","year":"2000","journal-title":"Diabetes Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2337\/dc07-0278","article-title":"Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes","volume":"30","author":"Guerin","year":"2007","journal-title":"Diabetes Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1172\/JCI22365","article-title":"The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion","volume":"115","author":"Gupta","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/953","article-title":"Mutations in the glucokinase gene of the fetus result in reduced birth weight","volume":"19","author":"Hattersley","year":"1998","journal-title":"Nat. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00125-023-05982-9","article-title":"Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing","volume":"66","author":"Hughes","year":"2023","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2337\/db07-1657","article-title":"Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations","volume":"57","author":"Kapoor","year":"2008","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.diabet.2011.04.002","article-title":"Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications","volume":"37","author":"Kyithar","year":"2011","journal-title":"Diabetes Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00125-021-05581-6","article-title":"Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study","volume":"65","author":"Locke","year":"2022","journal-title":"Diabetologia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e14488","DOI":"10.1111\/dme.14488","article-title":"Evaluation of pregnancy outcomes in women with GCK-MODY","volume":"38","author":"L\u00f3pez Tinoco","year":"2021","journal-title":"Diabet. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e53130","DOI":"10.1371\/journal.pone.0053130","article-title":"Computational modeling of glucose transport in pancreatic \u03b2-cells identifies metabolic thresholds and therapeutic targets in diabetes","volume":"7","author":"Luni","year":"2012","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e12378","DOI":"10.1371\/journal.pone.0012378","article-title":"Loss of hepatocyte-nuclear-factor-1alpha impacts on adult mouse intestinal epithelial cell growth and cell lineages differentiation","volume":"5","author":"Lussier","year":"2010","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1530\/EJE-21-0897","article-title":"Clinical and genetic heterogeneity of HNF4A\/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia","volume":"186","author":"McGlacken-Byrne","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/(SICI)1096-9136(199810)15:10<816::AID-DIA714>3.0.CO;2-P","article-title":"A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene","volume":"15","author":"Menzel","year":"1998","journal-title":"Diabet. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.2337\/diab.44.12.1408","article-title":"Localization of MODY3 to a 5-cM region of human chromosome 12","volume":"44","author":"Menzel","year":"1995","journal-title":"Diabetes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ajhg.2022.09.014","article-title":"Reduced penetrance of MODY-associated HNF1A\/HNF4A variants but not GCK variants in clinically unselected cohorts","volume":"109","author":"Mirshahi","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1126\/science.1089769","article-title":"Control of pancreas and liver gene expression by HNF transcription factors","volume":"303","author":"Odom","year":"2004","journal-title":"Science"},{"key":"B65","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2337\/dc13-3007","article-title":"Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial","volume":"37","author":"\u00d8stoft","year":"2014","journal-title":"Diabetes Care"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1371\/journal.pmed.0040118","article-title":"Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene","volume":"4","author":"Pearson","year":"2007","journal-title":"PLoS Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","article-title":"Genetic cause of hyperglycaemia and response to treatment in diabetes","volume":"362","author":"Pearson","year":"2003","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/embo-reports\/kvd071","article-title":"HNF1alpha controls renal glucose reabsorption in mouse and man","volume":"1","author":"Pontoglio","year":"2000","journal-title":"EMBO Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1210\/clinem\/dgad188","article-title":"Maternal and infant outcomes in GCK-MODY complicated by pregnancy","volume":"108","author":"Ren","year":"2023","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1210\/jc.2003-031552","article-title":"Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families","volume":"89","author":"Reznik","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/dme.13388","article-title":"Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer","volume":"34","author":"Shepherd","year":"2017","journal-title":"Diabet. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1007\/s00125-018-4728-6","article-title":"A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin","volume":"61","author":"Shepherd","year":"2018","journal-title":"Diabetologia"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s00125-010-1799-4","article-title":"Maturity-onset diabetes of the young (MODY): how many cases are we missing?","volume":"53","author":"Shields","year":"2010","journal-title":"Diabetologia"},{"key":"B48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1464-5491.2008.02622.x","article-title":"Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation","volume":"26","author":"Spyer","year":"2009","journal-title":"Diabet. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"E2026","DOI":"10.1210\/jc.2012-1356","article-title":"Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A","volume":"97","author":"Stanescu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jama.2013.283980","article-title":"Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia","volume":"311","author":"Steele","year":"2014","journal-title":"Jama"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e65326","DOI":"10.1371\/journal.pone.0065326","article-title":"Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies","volume":"8","author":"Steele","year":"2013","journal-title":"PloS one"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2337\/diacare.25.12.2287","article-title":"Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers","volume":"25","author":"Stride","year":"2002","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00125-013-3075-x","article-title":"Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia","volume":"57","author":"Stride","year":"2014","journal-title":"Diabetologia"},{"key":"B55","doi-asserted-by":"publisher","first-page":"802423","DOI":"10.3389\/fendo.2021.802423","article-title":"Pregnancy in women with monogenic diabetes due to pathogenic variants of the glucokinase gene: lessons and challenges","volume":"12","author":"Timsit","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.2337\/diacare.18.11.1446","article-title":"Congenital malformations in pregnancies complicated by NIDDM","volume":"18","author":"Towner","year":"1995","journal-title":"Diabetes Care"},{"key":"B57","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/pedi.12655","article-title":"Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations","volume":"19","author":"Tung","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ng0495-418","article-title":"A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q","volume":"9","author":"Vaxillaire","year":"1995","journal-title":"Nat. Genet."},{"key":"B59","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/pd.4832","article-title":"Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways","volume":"36","author":"Verhoef","year":"2016","journal-title":"Prenat. Diagn"},{"key":"B60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2337\/diacare.25.1.68","article-title":"Screening for MODY mutations, GAD antibodies, and type 1 diabetes--associated HLA genotypes in women with gestational diabetes mellitus","volume":"25","author":"Weng","year":"2002","journal-title":"Diabetes Care"},{"key":"B61","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/384458a0","article-title":"Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)","volume":"384","author":"Yamagata","year":"","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/384455a0","article-title":"Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)","volume":"384","author":"Yamagata","year":"","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.diabres.2006.08.001","article-title":"GCK and HNF1alpha mutations and polymorphisms in Polish women with gestational diabetes","volume":"76","author":"Zurawek","year":"2007","journal-title":"Diabetes Res. Clin. Pract."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1362977\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:26:24Z","timestamp":1718166384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1362977\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":63,"alternative-id":["10.3389\/fgene.2024.1362977"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1362977","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"article-number":"1362977"}}